Cargando…
Tegaderm CHG IV Securement Dressing for Central Venous and Arterial Catheter Insertion Sites: A NICE Medical Technology Guidance
Catheters are widely used for vascular access and for the administration of drugs or fluids in critically ill patients. This exposes patients to an infection risk. Tegaderm chlorhexidine gluconate (CHG) (developed by 3M)—a transparent securement dressing—covers and protects catheter sites and secure...
Autores principales: | Jenks, Michelle, Craig, Joyce, Green, William, Hewitt, Neil, Arber, Mick, Sims, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791453/ https://www.ncbi.nlm.nih.gov/pubmed/26458938 http://dx.doi.org/10.1007/s40258-015-0202-5 |
Ejemplares similares
-
Economic impact of Tegaderm chlorhexidine gluconate (CHG) dressing in critically ill patients
por: Thokala, Praveen, et al.
Publicado: (2016) -
Fitness of use of Biopatch® and Tegaderm(TM) CHG for protecting central venous catheters and arterial lines in critically ill patients
por: Eggimann, P, et al.
Publicado: (2015) -
The XprESS Multi-Sinus Dilation System for the Treatment of Chronic Sinusitis: A NICE Medical Technology Guidance
por: Jenks, Michelle, et al.
Publicado: (2017) -
Spectra Optia(®) for Automated Red Blood Cell Exchange in Patients with Sickle Cell Disease: A NICE Medical Technology Guidance
por: Willits, Iain, et al.
Publicado: (2017) -
SecurAcath for Securing Peripherally Inserted Central Catheters: A NICE Medical Technology Guidance
por: Macmillan, Tom, et al.
Publicado: (2018)